Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
Budget 2023
Budget 2023
you are here: HomeNewsBusiness

COVID-19 Vaccines | Biological E to begin producing 75-80 million doses of vaccine candidate from August 2021

The company is also starting Phase III trials of its recombinant protein vaccine candidate from August.

May 07, 2021 / 02:50 PM IST
Mahima Datla, MD of Biological E is confident that they will be able to come out of the gate running with 75-80 million doses per month “right from the start”. (Image Source: Shutterstock)

Mahima Datla, MD of Biological E is confident that they will be able to come out of the gate running with 75-80 million doses per month “right from the start”. (Image Source: Shutterstock)

Vaccine manufacturer Biological E is “gearing up” to produce 75-80 million doses per month of its recombinant protein vaccine candidate from August 2021, the Times of India reported.

The pharma company also said its vaccine will be “one of the most affordable” options in India.

Mahima Datla, MD of Biological E told the paper that while she is “not at liberty to share” details of pricing as it is still being worked out, “I can assure you it will be among the most affordable Covid-19 vaccines that you can get a hold of.”

Follow our LIVE Updates on the coronavirus pandemic here